Lori M. Minasian - Concepedia

Author

Lori M. Minasian

Also Known As

Basch, Ethan M., Carpenter, William R., Castro, Kathleen, Good, Marjorie, Gordon Willis, L M Minasian, L Minasian, L. M. Minasian, L. Minasian, L.M. Minasian

340

Publications

22.1K

Citations

H-Index

137

Concepts

All Affiliations

National Cancer Institute National Institutes of Health Fred Hutch Cancer Center The University of Texas MD Anderson Cancer Center University of North Carolina at Chapel Hill

About

Lori M. Minasian is an author at National Cancer Institute specializing in medicine, oncology, and clinical trials.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	45	3.2K
2	Health Sciences	9	9	421
3	Education	1	1	298
4	Management	1	1	298
5	Nursing	1	1	14

Lori M. Minasian

129

Publications

17.7K

Citations

H-Index

Page 1

	Year	Citations
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter Ian M. Thompson, Donna K. Pauler, Phyllis J. Goodman, New England Journal of Medicine	2004	2.4K
Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers Scott M. Lippman, Eric A. Klein, Phyllis J. Goodman, JAMA	2008	2.1K
Vitamin E and the Risk of Prostate Cancer Eric A. Klein, Ian M. Thompson, Catherine M. Tangen, JAMA	2011	1.7K
Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Ethan Basch, Bryce B. Reeve, Sandra A. Mitchell, JNCI Journal of the National Cancer Institute Cancer ManagementEpidemiology Of CancerCancer RegistrationCancer EducationCancer Clinical Research	2014	1.1K
Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Amylou C. Dueck, Tito R. Mendoza, Sandra A. Mitchell, JAMA Oncology	2015	979
Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy Halle C. F. Moore, Joseph M. Unger, Kelly‐Anne Phillips, New England Journal of Medicine	2015	530
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT) Scott M. Lippman, Phyllis J. Goodman, Eric A. Klein, JNCI Journal of the National Cancer Institute Chemoprevention StrategyCancer ManagementEpidemiology Of CancerPopulation Health SciencesPharmacotherapy	2005	355
Combination Targeted Therapy With Sorafenib and Bevacizumab Results in Enhanced Toxicity and Antitumor Activity Nilofer S. Azad, Edwin M. Posadas, Virginia E. Kwitkowski, Journal of Clinical Oncology	2008	336
Determinants of Implementation Effectiveness Christian D. Helfrich, Bryan J. Weiner, Martha M. McKinney, Medical Care Research and Review EducationImplementation EffectivenessComplex InnovationsOrganizational BehaviorProgram Evaluation	2007	298
Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up. Lori M. Minasian, Robert J. Motzer, Louis Gluck, Journal of Clinical Oncology	1993	292

Page 1